Skip to main content
OpenTrials
Completed

NCT Number: NCT05502471

Occludin and Zonulin in Attention-deficit/Hyperactivity Disorder

The association between levels of zonulin and occludin and behavioral/emotional problems in children with ADHD are investigated.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Attention-Deficit/Hyperactivity Disorder Attention Deficit Disorder with Hyperactivity Attention Deficit and Disruptive Behavior Disorders Mental Disorders Neurodevelopmental Disorders

Age range

6 year–12 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ataturk University Hospital

Erzurum, Turkey (Türkiye)

About this study

Inclusion criteria

for the ADHD group are (a) newly diagnosed ADHD (b) no prior psychotropic treatment for ADHD or any psychiatric disorder (c) age 6-12 years. Exclusion criteria were: (a) history of history of inflammatory/noninflammatory, metabolic, or autoimmune disease (b) any special diet history within the past year (c) use of corticosteroids or regular intake of medication in the last 6 months, (d) body mass index (BMI) [kg/m2] > 30), and (e) cognitive deficits by developmental history.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • (a) newly diagnosed ADHD
  • (b) no prior psychotropic treatment for ADHD or any psychiatric disorder
  • (c) age 6-12 years.

Exclusion criteria

  • (a) history of history of inflammatory/noninflammatory, metabolic, or autoimmune disease
  • (b) any special diet history within the past year
  • (c) use of corticosteroids or regular intake of medication in the last 6 months,
  • (d) body mass index (BMI) [kg/m2] > 30),
  • (e) cognitive deficits by developmental history

Treatment and study plan

Zonulin

Diagnostic Test

Serum zonulin level

Occludin

Diagnostic Test

Serum occludin level

Primary outcomes

  1. Zonulin level

    Time frame: 1 month

    Serum Zonulin level after psychiatric interview

  2. Occludin level

    Time frame: 1 month

    Serum Occludin level after psychiatric interview

Sponsors and collaborators

Lead sponsor

Ataturk University

Other

Registry information

Official study title

Serum Occludin and Zonulin Levels in Attention-deficit/Hyperactivity Disorder

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Aug 16, 2022
Registry last updated
Aug 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.